Search

everythinglearnresearchcommunity

for

Search:↓

A new genetic region, 17q21.31, is linked to higher ovarian cancer risk.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Birds can regenerate inner ear cells using specific gene pathways, unlike mammals.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Cyclosporin is effective for treating skin conditions in small animals, but requires careful dosing and monitoring for side effects.

RANK is a key target in breast cancer treatment due to its role in tumor growth and bone metastasis.

Hormonal treatments are effective for severe or persistent acne and should be used with other acne therapies, considering potential side effects.

Many patients find hair loss from chemotherapy very distressing, and while treatments like minoxidil and scalp cooling may help, there is no sure way to prevent it.

Male cancer patients have a higher risk of severe illness and death from COVID-19 than female patients.

FOXN1 mutations can cause varying immune and physical issues, with severity influenced by gene activity and possibly other factors.

Thymosin β4 helps improve skin healing and reduce scarring.

Natural products can help overcome cancer drug resistance.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

FDG PET/CT scans can change cancer treatment plans for dogs.

Proper skin toxicity management in chemotherapy is key to continuing treatment and keeping patient quality of life high.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

Short telomeres contribute to aging and cancer, and while telomerase can delay aging, it may also promote cancer.

LRIG1 is linked to better survival in Merkel cell carcinoma.

Understanding and manipulating epigenetic changes can potentially lead to human organ regeneration therapies, but more research is needed to improve these methods and minimize risks.

Hormonal therapies, like flutamide and cyproterone acetate, are safe and effective for treating adult women's acne, especially those with hormone imbalance or resistant acne.

Stem cell therapies show promise for treating various diseases but face challenges in clinical use and require better monitoring techniques.

Biomaterials combined with stem cells show promise for improving tissue repair and medical treatments.

Runx genes are important for stem cell regulation and their roles in aging and disease need more research.

Nano-quercetin improves quercetin's effectiveness in treating diseases but faces challenges in safety and production.

New treatments for relapsing multiple sclerosis are more effective and convenient but have higher risks of serious side effects.

Cancer treatments often cause hair loss, and more research is needed to prevent and treat it.

Stopping forehead irritation and using hydrocortisone helped a man's skin, Martinique has lower melanoma rates, a man had an allergy to a specific antifungal, another had unexplained cysts, certain drugs can cause skin reactions without always being interrelated, a link between Fanconi anemia and a skin condition was suggested, high levels of a certain protein may play a role in a type of psoriasis, and there's a need to study the connection between scalp pain and hair loss.

Cladribine has known risks and potential new safety concerns, requiring careful monitoring.

EGFR inhibitors for lung cancer can cause severe skin issues.

Tyrosine kinase inhibitors show promise in treating some skin diseases but their definitive role in dermatology is still unclear.